A pharmaceutical company is deciding whether to invest in the development of a new drug. The development process is expected to take several years and requires significant upfront investment, but the drug has the potential to generate substantial revenue if successful. The company is unsure about the market demand and regulatory approval for the new drug. Which financial model should be used to evaluate this decision